CapitalSource (CSE) Appoints DaVita (DVA) Exec Mello to Board
Tweet Send to a FriendGet Alerts CSE Hot Sheet
Price: $9.29 -0.32%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 0.4%
EPS Growth %: +40.0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 0.4%
EPS Growth %: +40.0%
Trade CSE Now!
CapitalSource Inc. (NYSE: CSE) today announced that Joseph C. Mello has been elected to its Board of Directors. He will complete the term, expiring at the Company's 2014 Annual Meeting, of Frederick W. Eubank who previously retired from the Board. CapitalSource, through its wholly owned subsidiary CapitalSource Bank, makes commercial loans to small and middle-market businesses nationwide and offers depository products and services in 21 retail branches in southern and central California.
Mr. Mello is an experienced healthcare executive. He currently is the Chief Operating Officer-Emeritus of dialysis services company Da Vita Inc. (NYSE: DVA), having served in the COO role from 2000-2009. He previously served as President and Chief Executive Officer of Vivra Asthma & Allergy Inc. and held executive roles with MedPartners Inc. and Caremark Inc.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Mr. Mello is an experienced healthcare executive. He currently is the Chief Operating Officer-Emeritus of dialysis services company Da Vita Inc. (NYSE: DVA), having served in the COO role from 2000-2009. He previously served as President and Chief Executive Officer of Vivra Asthma & Allergy Inc. and held executive roles with MedPartners Inc. and Caremark Inc.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- JPMorgan (JPM) Shareholders Support Dimon in Dual Role
- Tessera (TSRA), Starboard Reach Agreement Over Board Composition
- Biogen Idec (BIIB) Appoints Spyros Artavanis-Tsakonas as CSO
Create E-mail Alert Related Categories
Management ChangesLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

